These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7795044)
21. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis. Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438 [TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70. Dai FY; Wang JF; Gong XL; Bao L Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284 [TBL] [Abstract][Full Text] [Related]
24. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis. Dhar N; Rao V; Tyagi AK FEMS Microbiol Lett; 2000 Sep; 190(2):309-16. PubMed ID: 11034297 [TBL] [Abstract][Full Text] [Related]
25. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
26. Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes. Oliveira TL; Rizzi C; Dellagostin OA Appl Microbiol Biotechnol; 2017 Sep; 101(18):6865-6877. PubMed ID: 28779291 [TBL] [Abstract][Full Text] [Related]
27. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice. Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737 [TBL] [Abstract][Full Text] [Related]
28. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned. Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040 [TBL] [Abstract][Full Text] [Related]
31. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice. Li W; Li M; Deng G; Zhao L; Liu X; Wang Y Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection. Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942 [TBL] [Abstract][Full Text] [Related]
33. A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. Hoft DF; Blazevic A; Abate G; Hanekom WA; Kaplan G; Soler JH; Weichold F; Geiter L; Sadoff JC; Horwitz MA J Infect Dis; 2008 Nov; 198(10):1491-501. PubMed ID: 18808333 [TBL] [Abstract][Full Text] [Related]
34. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis. Xing Z; Charters TJ Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008 [TBL] [Abstract][Full Text] [Related]